Summary
Cigarette smoke contains toxic and carcinogenic substances that contribute to the development of cancer and various diseases. Genetic variation might be important, because not all smokers develop smoking-related disease. The current study addressed the possible interactions among selected single nucleotide polymorphisms (SNPs) in genes related to systemic inflammation, smoking status, the levels of circulating immune response cells and plasma biomarkers of systemic inflammation. Sixtyfour healthy blood donors were recruited, 31 of whom were current smokers and 33 were never-users of tobacco products, references. Compared to references, the smokers showed significantly increased levels of circulating total white blood cells, lymphocytes, monocytes, neutrophils, basophils and C-reactive protein (CRP 
Introduction
Cigarette smoking is a significant risk factor for diseases in the cardiovascular system, respiratory system and several types of cancer. [1] [2] [3] However, not all smokers develop smoking-related disease. Genetic susceptibility might play a role because an increased risk -at least for some types of cancer -has also been reported among non-smoking, first-degree relatives. 4, 5 In vitro, smoke extract alters normal cell phenotypes and gene expression profiles and can induce massive cell death. Such effects were found to be associated with certain single nucleotide polymorphism (SNP) genotypes. 6, 7 Cell death induced by smoking may trigger a local or systemic inflammatory response that results in endothelial cell activation, the promotion of a prothrombotic stage and atherosclerotic plaque formation. 8, 9 The extent of systemic inflammation can be assessed by the plasma Creactive protein (CRP) levels. 10 Increased plasma CRP levels are associated with a poor clinical outcome among 
head and neck cancer patients, independently of tumournode-metastasis (TNM) staging. 11 Elevated levels of circulating blood lymphocytes, monocytes and neutrophils are associated with inflammation and poor survival in cancer patients. 12 Monocytes and neutrophils play a major role in the innate immune response and interact with adaptive immune response cells in the lymphocyte group. 13 Such interactions could result in either the activation or suppression of the host immune response. 14 
CD8
+ cells in the T-lymphocyte group could be divided into a highly expressed CD8 level (CD8 bright ) based on the a/b heterodimers or a lower expressed CD8 level (CD8 dim ) based on the a/a homodimers receptor. The function of these CD8 subpopulations might differ. 15, 16 Increased levels of CD8 dim suggest an immunosuppressed state 17 and cytotoxic T-lymphocyte (CTL) impairment, 18 and have been associated with disease progression in human immunodeficiency virus (HIV)-positive patients.
19
Perforin (PRF) and granzyme B (GZB) are cytotoxic granules that mediate cell death. 20 Over-expression of granzyme B (GZB) in CD8 + T-lymphocytes is a putative biomarker of impaired immunity detected in patients with systemic lupus erythematosus. 21 The current study addressed the possible interactions among selected SNPs in genes related to systemic inflammation, smoking status and the levels of circulating immune response cells and plasma biomarkers of systemic inflammation.
Materials and methods

Subjects
We recruited 31 healthy blood donors who, according to selfreports, were current smokers (eight males and 23 females with a median age of 57 years). The preponderance of females was probably a reflection of the fact that in Sweden, contrary to the situation in most other countries, the prevalence of smoking is higher among females than it is among males. 3 A sample of donors who reported having never used any type of tobacco product was matched to the group of smokers on the basis of age and gender. This resulted in a reference group with a total of 33 individuals (six males and 27 females, with a median age of 54 years).
All study subjects provided informed consent to participate in this study, according to the Declaration of Helsinki. Ethics approval was obtained from the regional ethical review board of Link€ oping, Sweden.
Blood samples and flow cytometry
Thirty millilitres of venous blood was collected from all participants. The levels of circulating total white blood cells (WBCs) and subpopulations were analysed with a Sysmex XE5000 instrument (Sysmex Corporation, Kobe, Japan).
The phenotypes of ex-vivo fresh peripheral WBC subpopulations were analysed using a Becton Dickinson FACSCanto II flow cytometer (BD Biosciences, San Jose, CA). All monoclonal antibodies were purchased from BD Biosciences. The cells were directly stained with surface markers for CD3, CD4, CD8, CD11, CD13, CD14 and CD56, and were intracellularly stained for GZB and PRF according to the company protocol. Peripheral blood lymphocyte, monocyte and neutrophil subpopulations were analysed after gating according to their SSC/FSC location ( Fig. 1) . Data analysis was performed with the BD FACSDIVA software program (BD Biosciences).
Plasma CRP analysis
Plasma CRP levels were analysed using Siemens Advia 1800 (Siemens Healthcare, Erlangen, Germany).
DNA samples and SNP analysis
High molecular-weight DNA was extracted from the blood samples using a Qiagen Bio Robot M48 with MagAttract DNA Blood M48 kit (www.qiagen.com). The quantity and quality of DNA were determined by spectrophotometric analysis (Nanodrop ND-1000; Nanodrop Technologies, Wilmington, DE, USA). These DNA samples were used as templates in the SNP detection.
Four SNPs located in CRP rs1800947, GZB rs8192917, PRF rs10999426 and PRF rs3758562 were analysed. These SNPs were tested and passed the two-hits in the dbSNP database or HapMap-validated SNPs with an Illumina design ability score. Genotyping of the candidate SNPs was performed by the Golden Gate assay (www.illumina.com), according to the manufacturer's protocol, 22 at the SNP and SEQ Technology Platform, Uppsala University, Sweden (www.genotyping.se).
Statistics
The Mann-Whitney U-test was used for distributional comparisons using SPSS 18 : SPSS Inc., Chicago, Illinois, USA. All comparisons were two-sided, with a Pvalue ≤ 0Á05 considered statistically significant. Correction for multiple testing was performed according to Benjamini and Hochberg, 23, 24 with a false discovery rate of 0Á05.
Results
WBCs and WBC subpopulations
A significantly increased level of circulating total WBCs, lymphocytes, monocytes, neutrophils and basophils was detected among the smokers compared to the reference subjects ( phenotypes were also significantly increased among the smokers, as was the level of monocytes with CD13 + CD14 + expression ( Fig. 1 and Table 1b ). In the lymphocyte gate, the level of CD3 + , CD8 + and CD8 dim cells was significantly increased among the smokers ( Fig. 2 and Table 1c) .
No statistically significant differences were detected in terms of the level or phenotype of WBCs or WBC subpopulations between young and old subjects (≤ 55 versus > 55 years). This observation applied to both smokers and never-smoking subjects, references (data not shown).
Plasma CRP
There was a highly significant difference (P = 0Á009) between the level of plasma CRP among the smokers (median = 2Á57 mg/l, min-max: 0Á27-16Á16) compared to the reference subjects (median = 1Á34 mg/l, min-max: 0Á23-7Á38).
SNPs and smoking status
No difference in the distribution SNP frequencies of gene CRP rs1800947, GZB rs8192917, PRF rs10999426 and PFR rs3758562 was observed among the smokers compared to the reference subjects (data not shown). However, the highest level of CRP was noted among smokers who had the CRP rs1800947 CC genotype (P = 0Á03, Table 2) .
A significantly increased level of CD8 + GZB + cells was observed among the smokers exhibiting the GZB rs8192917 AA genotype. This increase mainly concerned CD8 dim GZB + cells with the GZB rs8192917 AA genotype (Table 2) .
No difference was observed between smokers and references in terms of PRF expression in CD4 + , CD8 + , CD8 bright or CD8 dim cells related to the PRF rs10999426 or PRF rs3758562 genotype polymorphism (data not shown).
Discussion
We have previously shown that cigarette smoke condensate induced massive cell death in vitro. 6 Based on this observation, we hypothesized that the autoantigens released from dead cells in vivo may provoke a local host immune response. In this investigation, we observed significantly increased levels of circulating total WBCs, lymphocytes, monocytes, neutrophils, basophils and plasma CRP among healthy smokers. This observation confirms that cigarette smoke can, in fact, induce a systemic inflammatory host immune response in vivo. Chronic systemic inflammation has been suggested to contribute not only to the increased risk of cancer among smokers, but also to smoking-related cardiovascular disease. 2, 8 It has been reported that young smokers exhibit increased levels of circulating CD4 + (but not CD8 + ) cells compared to their non-smoking monozygotic twins. 25 We observed elevated levels of circulating CD8 dim cells among the smokers compared to the reference subjects. The discrepancy between our findings and the mentioned results might be related to the different composition of the reference groups (identical monozygotic twins versus unrelated healthy blood donors). However, it is also possible that monozygotic twins of smokers might be exposed to second-hand smoke to a greater extent than non-smoking, unrelated individuals. 25 The intensity of CD8 expression has been suggested to constitute an indicator of the host immunological profile. 15, 17 Increased circulating CD8 dim cells have been documented among HIV-infected individuals and are associated with peripheral T-cell exhaustion or impairment of effective CTL. 19 Additionally, among laboratory animals with an experimental simian immunodeficiency virus infection, an increased level of CD8 dim cells was correlated with impaired immune function. 18 It has been reported that increased levels of CD8 + GZB + cells constitute an abnormal adaptive immune response mediator. 26 The increase in circulating CD8 dim GZB + cells observed in our study provides further support for the hypothesis that smoking may also induce a state of immunosuppression among apparently healthy individuals. Our results extend previous findings showing that smoke extracts in vitro or smoking status in vivo affect various immunological functions. For instance, in-vitro exposure to cigarette smoke was found to impair myeloid cell differentiation. 27 An increased level of circulating CD13 + CD11 + or CD13 + CD56 + cells in monocytes and neutrophils among smokers, which was detected in our investigation, suggested a smoking related-impairment of the host systemic innate immune response. 27, 28 We observed an increased level of CD8 dim GZB + cells among smokers that was associated with the GZB rs8192917 AA genotype. We also observed an increased plasma CRP level among the smoking subjects that was associated with the CRP rs1800947 CC genotype. The effect of smoking was more pronounced among individuals exhibiting the studied SNPs, and was not observed for all smokers. Thus, the risk among smokers to develop smoking-related disease might be associated with specific SNPs that are related to immune function. [29] [30] [31] In conclusion, our investigation suggests that genetic variation at SNPs sequences might predict the risk of smoking-related disease. Thus, using SNPs as a predictive biomarker of individual risk or as additional motivation for smoking cessation merit further investigation.
